Bionexo
PrivateLast Round
Growth Equity
Oct 20, 2023
Est. Valuation
$200.2M
Total Funding Raised
$101.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Bionexo operates in Healthcare & Life Sciences and is based in São Paulo. Its latest recorded funding round was a Growth Equity round in October 2023.
Bionexo is a health tech company that provides an integrated suite of cloud software and a B2B marketplace to help hospitals and healthcare providers source critical care products and manage supply chain processes.
Sector
Healthcare & Life Sciences
Verticals
Supply Chain, Vertical SaaS, E-commerce, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bionexo Comparables
Compare Bionexo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GHX Europe | 78% | |
| Procurement Partners | 67% | |
| Huma Tecnologia | 66% |
For institutional investors. Book with your work email.
Bionexo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Oct 20, 2023 | ||||
| Growth Equity | Oct 15, 2021 | ||||
| VC Round | Dec 13, 2018 | ||||
| Private Equity | Mar 24, 2017 | ||||
| VC Round | Jul 17, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bionexo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Temasek | Growth Equity |
| Apus Capital | Growth Equity |
| Bain Capital, LP | Growth Equity |
| Insight Partners | VC Round |
| Prisma Capital | Growth Equity, Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 38% MoM.
- Jul 23, 2026
Grew 73% QoQ, from 509 to 882 employees.
For institutional investors. Book with your work email.
Bionexo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bionexo's valuation, stock price, and market status.
Is Bionexo a public or private company?
Bionexo is a private company.
What is the current stock price of Bionexo?
Bionexo is a private company, so its shares have no public market price. Caplight tracks Bionexo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bionexo worth (valuation)?
Bionexo's valuation is estimated at $200.2M based on funding round data.
Can I buy Bionexo stock?
Bionexo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bionexo's last funding round?
Bionexo's most recent funding round was Growth Equity on October 20, 2023.
Who are the main investors in Bionexo?
Key investors in Bionexo include Bain Capital, LP, Insight Partners, Prisma Capital.
Will Bionexo IPO soon?
No public IPO plans have been announced for Bionexo.
How can I track Bionexo secondary market activity?
Caplight tracks bids, offers, and trades in Bionexo's shares on secondary markets.